Beryl Drugs Limited announced earnings results for the third quarter ended December 31, 2018. For the third quarter, the company announced total revenue was INR 30.110 million compared to INR 36.345 million a year ago. Operating income was INR 2.022 million compared to INR 1.324 million a year ago. Net income was INR 1.440 million compared to INR 1.024 million a year ago. Basic earnings per share was INR 0.284 compared to INR 0.202 a year ago. For the nine months, total revenue was INR 107.942 million compared to INR 117.591 million a year ago. Operating income was INR 7.095 million compared to INR 3.148 million a year ago. Net income was INR 4.872 million compared to INR 6.796 million a year ago. Basic earnings per share was INR 0.961 compared to INR 1.34 a year ago.